We are live on ! Find out more
BMO

Beck Mack & Oliver Portfolio holdings

AUM $4.85B
1-Year Est. Return 9.66%
This Fund
S&P 500
This Quarter Est. Return
+13.12%
1 Year Est. Return
+9.66%
3 Year Est. Return
+69.39%
5 Year Est. Return
+96.17%
10 Year Est. Return
+350.87%
AUM
$4.3B
AUM Growth
+$479M
Cap. Flow
-$13.7M
Cap. Flow %
-0.32%
Top 10 Hldgs %
47.06%
Holding
186
New
16
Increased
26
Reduced
83
Closed
3

Top Buys

Rank Stock Value
1
RUSHA icon
Rush Enterprises Class A
RUSHA
+$5.46M
2
FERG icon
Ferguson
FERG
+$3.54M
3
OWL icon
Blue Owl Capital
OWL
+$3.32M
4
FTRE icon
Fortrea Holdings
FTRE
+$3M
5
SCHW
Charles Schwab
SCHW
+$2.76M

Top Sells

Rank Stock Value
1
SHW icon
Sherwin-Williams
SHW
+$7.68M
2
WMS icon
Advanced Drainage Systems
WMS
+$7.19M
3
TEVA icon
Teva Pharmaceuticals
TEVA
+$6.95M
4
MSFT icon
Microsoft
MSFT
+$5.14M
5
MA icon
Mastercard
MA
+$3.07M

Sector Composition

Rank Sector Weight
1 Financials 40.69%
2 Healthcare 13.57%
3 Technology 12.87%
4 Communication Services 7.57%
5 Industrials 7.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FISV
26
Fiserv Inc
FISV
$29.7B
$62.2M 1.45%
468,439
-12,155
-3% -$1.49M
QCOM icon
27
Qualcomm
QCOM
$164B
$60.9M 1.42%
420,828
-6,947
-2% -$860K
MTDR icon
28
Matador Resources
MTDR
$6.04B
$60.3M 1.4%
1,059,900
+19,703
+2% +$1.15M
SHW icon
29
Sherwin-Williams
SHW
$84.8B
$59.3M 1.38%
190,048
-28,544
-13% -$7.68M
MKL icon
30
Markel Group
MKL
$25.2B
$44.6M 1.04%
31,386
-1,940
-6% -$2.75M
UNP icon
31
Union Pacific
UNP
$174B
$43.9M 1.02%
178,745
-621
-0.3% -$137K
JNJ icon
32
Johnson & Johnson
JNJ
$640B
$42.9M 1%
273,384
+70
+0% +$10.7K
MA icon
33
Mastercard
MA
$498B
$42.2M 0.98%
98,840
-7,639
-7% -$3.07M
RUSHA icon
34
Rush Enterprises Class A
RUSHA
$6.34B
$39M 0.91%
774,736
+135,295
+21% +$5.46M
WAB icon
35
Wabtec
WAB
$49.3B
$37.2M 0.86%
292,999
-2,750
-0.9% -$310K
GSAT icon
36
Globalstar
GSAT
$10.1B
$35.8M 0.83%
1,229,366
-3,074
-0.2% -$67.6K
LOW icon
37
Lowe's Companies
LOW
$121B
$34.8M 0.81%
156,458
-2,943
-2% -$597K
AAPL icon
38
Apple
AAPL
$4.97T
$25.7M 0.6%
133,468
-795
-0.6% -$147K
TEVA icon
39
Teva Pharmaceuticals
TEVA
$40.4B
$25.4M 0.59%
2,432,214
-744,898
-23% -$6.95M
WBD icon
40
Warner Bros
WBD
$64.3B
$24.8M 0.58%
2,182,528
-100,687
-4% -$1.09M
BN icon
41
Brookfield
BN
$102B
$23.8M 0.55%
889,881
-16,269
-2% -$369K
HUBB icon
42
Hubbell
HUBB
$24.4B
$18.3M 0.43%
55,765
-400
-0.7% -$120K
DOV icon
43
Dover
DOV
$26.7B
$18M 0.42%
116,964
-6,327
-5% -$886K
WMT icon
44
Walmart Inc
WMT
$909B
$17.9M 0.42%
339,942
-3,426
-1% -$181K
WMB icon
45
Williams Companies
WMB
$85.8B
$17.6M 0.41%
505,495
-800
-0.2% -$28.1K
PKE icon
46
Park Aerospace
PKE
$720M
$14.8M 0.34%
1,005,147
+73,057
+8% +$1.09M
MRK icon
47
Merck
MRK
$322B
$14.7M 0.34%
134,461
-599
-0.4% -$62.2K
SYY icon
48
Sysco
SYY
$40.8B
$14M 0.33%
192,086
-392
-0.2% -$27.1K
ENB icon
49
Enbridge
ENB
$120B
$13.5M 0.31%
375,776
-321
-0.1% -$10.8K
DUK icon
50
Duke Energy
DUK
$101B
$12.7M 0.3%
130,799
-261
-0.2% -$23.7K
1
2
3 4 5

Similar funds

SCA
Southpoint Capital Advisors New York $4.86B AUM 34.09% 1-Year Est. Return
MCCA
Mill Creek Capital Advisors Conshohocken, Pennsylvania $4.87B AUM 17.69% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
TPCW
TD Private Client Wealth New York $4.82B AUM 15.21% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
JSTA
Japan Science & Technology Agency Tokyo, Japan $4.81B AUM 4.62% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
KCM
Kensico Capital Management Greenwich, Connecticut $4.9B AUM 41.26% 1-Year Est. Return

Beck Mack & Oliver's Q4 2023 Portfolio in Review

As of Q4 2023, Beck Mack & Oliver held 186 positions worth $4.3B, up 13% from $3.82B the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Beck Mack & Oliver's Q4 2023 filing shows 16 new, 26 increased, 83 reduced and 3 closed positions. Its largest new stake was CVS Health: 21,339 shares worth $1.68M. The largest sale was Sherwin-Williams, an estimated $7.68M.

By sector, the portfolio is most concentrated in Financials at 41% of assets, up from 41% a quarter earlier, followed by Healthcare and Technology.

  • Beck Mack & Oliver's largest Q4 2023 buy was CVS Health: 21,339 shares worth $1.68M.
  • Beck Mack & Oliver added most to Rush Enterprises Class A in Q4 2023, an estimated $5.46M increase.
  • Beck Mack & Oliver's biggest Q4 2023 reduction was Sherwin-Williams, cutting an estimated $7.68M.
  • Beck Mack & Oliver fully exited General Mills in Q4 2023, selling an estimated $384K.
  • Beck Mack & Oliver's ten largest holdings make up 47% of its $4.3B portfolio in Q4 2023.
  • Beck Mack & Oliver opened 16 new positions and closed 3 in Q4 2023.
  • Beck Mack & Oliver's portfolio value rose 13% quarter-over-quarter to $4.3B.

Based on Beck Mack & Oliver's 13F filing for Q4 2023, filed 14 Feb 2024.